• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
EFdA (Islatravir): An Outstanding Anti-HIV Modified Nucleoside: From Conceptualization to Present-Day Clinical Findings

EFdA (Islatravir): An Outstanding Anti-HIV Modified Nucleoside: From Conceptualization to Present-Day Clinical Findings

Paperback

Medical ReferenceBiology

ISBN13: 9798892481762
Publisher: Bayshop (Generis Publishing)
Published: Feb 9 2026
Pages: 68
Weight: 0.31
Height: 0.18 Width: 6.00 Depth: 9.00
Language: English
EFdA(4'-C-ethynyl-2-fluoro-2'-deoxyadenosine), named Islatravir by Merck, is a very excellent anti-HIV modified nucleoside. The story of its development, especially the basis of its design, advances in its synthetic methods, amazing clinical results and unexpected clinical results, and further, the possibility of EFdA as the clinical medicine, is described.

Also in

Biology